Related Experiment Video

Updated: Jul 19, 2026

Consensus Brain-derived Protein, Extraction Protocol for the Study of Human and Murine Brain Proteome Using Both 2D-DIGE and Mini 2DE Immunoblotting
10:51

Consensus Brain-derived Protein, Extraction Protocol for the Study of Human and Murine Brain Proteome Using Both 2D-DIGE and Mini 2DE Immunoblotting

Published on: April 10, 2014

A deletion polymorphism of alpha(2)-macroglobulin gene and cerebral amyloid angiopathy

M Yamada1, N Sodeyama, Y Itoh

  • 1Department of Neurology, Tokyo Medical and Dental University, Japan. m-yamada.nuro@med.tmd.ac.jp

Stroke
|November 5, 1999
PubMed
Abstract

Insights

The alpha(2)-macroglobulin (A2M) deletion polymorphism was not found to be a significant risk factor for cerebral amyloid angiopathy (CAA) severity in elderly individuals. Further research with larger cohorts is needed to confirm these findings for Alzheimer's disease (AD) genetics.

Area of Science:

  • Neurogenetics
  • Neuropathology
  • Molecular Biology

Background:

  • Alpha(2)-macroglobulin (A2M) is potentially involved in amyloid beta protein deposition.
  • A specific A2M gene deletion (exon 18 splice acceptor) has been linked to Alzheimer's disease (AD) risk.
  • Cerebral amyloid angiopathy (CAA) is a cerebrovascular condition associated with amyloid deposition.

Purpose of the Study:

  • To investigate the association between the A2M deletion polymorphism and the severity of cerebral amyloid angiopathy (CAA).
  • To identify potential genetic risk factors for CAA.
  • To explore the role of A2M in the pathogenesis of CAA.

Main Methods:

  • The study analyzed 178 elderly autopsy cases, including 68 with Alzheimer's disease (AD).
  • The severity of CAA was assessed in relation to the presence or absence of the A2M deletion polymorphism.
  • The influence of the apolipoprotein E (APOE) epsilon4 allele on the results was also evaluated.

Main Results:

  • No significant difference in CAA severity was observed between individuals with and without the A2M deletion allele.
  • This lack of association was consistent across AD, non-AD, and total case groups.
  • APOE epsilon4 allele status did not alter the observed results regarding A2M deletion and CAA severity.

Conclusions:

  • The A2M deletion polymorphism may not be a definitive genetic risk factor for CAA in the elderly population.
  • Larger sample sizes are required to definitively confirm or refute this association.
  • Further investigation into the genetic underpinnings of CAA is warranted.

More Related Videos

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment07:26

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

Published on: July 18, 2017

Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry09:31

Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry

Published on: March 7, 2019

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
RNA Editing02:23

RNA Editing

RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...